Jeff Weisel | Corporate Strategy Advisor
Ardion | Singapore

Jeff has more than 20 years' experience working with leading organisations across the life sciences and healthcare value chain in Asia Pacific. His roles have encompassed executive positions in the biopharma industry with Novartis and AbbVie as well as leadership of Big 4 consulting practices. Areas of focus include corporate strategy, business development & licensing, market and patient access, health financing and real world evidence. He has been active in the Singapore start-up ecosystem as advisor and investor for multiple biotech and healthtech companies and through serving as a mentor in the NUS GRIP program and as a panelist for the National Health Innovation Centre.